title: The ORACLE I and II randomised trial results do not remove the need for prophylaxis against early onset Group B streptococcal disease.
authors.forename: A Christine
authors.initials: AC
authors.lastname: McCartney
authors.forename: Paul
authors.initials: P
authors.lastname: Health
authors.forename: Rhona
authors.initials: R
authors.lastname: Hughes
authors.forename: Albert
authors.initials: A
authors.lastname: Mifsud
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Price
mesh_terms: D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D006801:Humans; D015337:Multicenter Studies as Topic; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D013290:Streptococcal Infections / Q000517:prevention & control*; D013292:Streptococcus agalactiae